What is Dentbird?
Operating under the Imagoworks umbrella, Dentbird is dedicated to transforming the landscape of dental medicine through sophisticated AI integration. The company provides a comprehensive digital ecosystem designed to empower dental professionals with high-precision tools that simplify complex procedures and improve diagnostic accuracy. By bridging the gap between traditional dental practices and cutting-edge digital technology, Dentbird enables clinicians to optimize their operational efficiency while simultaneously elevating the standard of care for patients. Their market position is defined by a commitment to accessibility and innovation, effectively removing the barriers that have historically hindered the adoption of advanced digital solutions in the dental field.
How much funding has Dentbird raised?
Dentbird has raised a total of $15.6M across 1 funding round:
Series C
$15.6M
Series C (2024): $15.6M with participation from K2 Investment, TS Investment, Industrial Bank of Korea, and STIC Ventures
Key Investors in Dentbird
K2 Investment
K2 Investment specializes in overseas investments, hedge funds, and private banking services, providing expert financial advice to facilitate global capital allocation.
TS Investment
TS Investment Corp is a professional investment firm operating within the consumer services sector, focusing on high-growth potential enterprises.
Industrial Bank of Korea
A leading financial institution with a long history of supporting small and midsized enterprises through comprehensive banking and asset management solutions.
What's next for Dentbird?
With the successful closure of this major strategic investment, Dentbird is well-positioned to accelerate its research and development initiatives, focusing on the expansion of its AI-driven feature set and the broadening of its international market footprint. The company is expected to prioritize the scaling of its enterprise-grade infrastructure, ensuring that its platform remains the gold standard for digital dentistry. Furthermore, the strategic alignment with its current investor base provides the necessary capital and institutional expertise to navigate the complexities of the global medical technology market. As Dentbird continues to refine its technological offerings, the focus will likely shift toward deeper integration with existing clinical hardware and the development of predictive analytics tools that further enhance the precision of dental interventions.
See full Dentbird company page
